News

  • IDRI launches Phase I trial of leprosy vaccine

    Infectious Disease Research Institute (IDRI) and American Leprosy Missions in the US have launched a Phase I clinical trial to evaluate a vaccine candidate, LepVax, specifically developed for leprosy.